A flow cytometry blood test can be part of the process of diagnosing certain diseases, including blood cancers such as leukemia or lymphoma. Scientists also use flow cytometry in medical research.

Actually, flow cytometry enables to detect some divergent ... To explain the worse prognosis of CD56 acute leukemia, different hypotheses have been proposed, including a greater occurrence in ...

Researchers have developed a new methodology for the characterization of circulating leukemia cells, and other low-abundance cells, by flow cytometry. The technique enables quantification of ...

Flow cytometry has been applied to immunology ... Reagent System provides U.S. clinical labs with a unique integrated leukemia and lymphoma testing method. The DxFLEX Flow Cytometer gives U.S ...

Using existing flow-cytometric data from medical records that ... a manifestation of undetected leukemia present months to years before the manifestations of CLL. However, for the majority of ...

A new liquid biopsy test that uses flow cytometry to detect cancer cells has been FDA approved for chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome ...

It has become a common technique for the identification and classification of acute leukemias, particularly acute myeloid leukemia (AML). In flow cytometry, the sample may range from blood ...

I can tell you that from work we've done with the NIH, trying to standardize flow cytometry in the leukemia setting across different well-known labs is really problematic. Obviously, if someone ...

For the past 65 years, more than 1.5 million people with blood cancers such as leukemia and lymphoma have been saved ... undergo an additional transplantation procedure. This is why flow cytometry ...

The EuroFlow Consortium began to publish their recommendations for leukemia and lymphoma testing in 2007 (6). Recommendations specific to the validation of flow cytometric methods were first published ...

Among patients with CR, the MRD negativity rate was 95.5% (95% CI, 77.2-99.9) based on flow cytometry and 86.4% (95% CI, 65.1-97.1) based on real-time PCR. The most common adverse reactions ...